These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 22974472)

  • 1. A randomized, double-blind, placebo-controlled trial of citicoline for bipolar and unipolar depression and methamphetamine dependence.
    Brown ES; Gabrielson B
    J Affect Disord; 2012 Dec; 143(1-3):257-60. PubMed ID: 22974472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized, placebo-controlled trial of citicoline add-on therapy in outpatients with bipolar disorder and cocaine dependence.
    Brown ES; Gorman AR; Hynan LS
    J Clin Psychopharmacol; 2007 Oct; 27(5):498-502. PubMed ID: 17873684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Randomized, Double-Blind, Placebo-Controlled Trial of Citicoline for Cocaine Dependence in Bipolar I Disorder.
    Brown ES; Todd JP; Hu LT; Schmitz JM; Carmody TJ; Nakamura A; Sunderajan P; Rush AJ; Adinoff B; Bret ME; Holmes T; Lo A
    Am J Psychiatry; 2015 Oct; 172(10):1014-21. PubMed ID: 25998279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Citicoline Combination Therapy for Major Depressive Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Roohi-Azizi M; Arabzadeh S; Amidfar M; Salimi S; Zarindast MR; Talaei A; Akhondzadeh S
    Clin Neuropharmacol; 2017; 40(1):1-5. PubMed ID: 28085707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Randomized, Double-Blind, Placebo-Controlled Trial of Citicoline in Patients with Alcohol Use Disorder.
    Brown ES; Van Enkevort E; Kulikova A; Escalante C; Nakamura A; Ivleva EI; Holmes T
    Alcohol Clin Exp Res; 2019 Feb; 43(2):317-323. PubMed ID: 30457668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjunctive armodafinil for major depressive episodes associated with bipolar I disorder: a randomized, multicenter, double-blind, placebo-controlled, proof-of-concept study.
    Calabrese JR; Ketter TA; Youakim JM; Tiller JM; Yang R; Frye MA
    J Clin Psychiatry; 2010 Oct; 71(10):1363-70. PubMed ID: 20673554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Double-blind, placebo-controlled trial of pioglitazone for bipolar depression.
    Aftab A; Kemp DE; Ganocy SJ; Schinagle M; Conroy C; Brownrigg B; D'Arcangelo N; Goto T; Woods N; Serrano MB; Han H; Calabrese JR; Gao K
    J Affect Disord; 2019 Feb; 245():957-964. PubMed ID: 30699881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Demographic variables, design characteristics, and effect sizes of randomized, placebo-controlled, monotherapy trials of major depressive disorder and bipolar depression.
    Papakostas GI; Martinson MA; Fava M; Iovieno N
    J Clin Psychiatry; 2016 May; 77(5):e619-24. PubMed ID: 27249092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Double-blind placebo-controlled study with citicoline in APOE genotyped Alzheimer's disease patients. Effects on cognitive performance, brain bioelectrical activity and cerebral perfusion.
    Alvarez XA; Mouzo R; Pichel V; Pérez P; Laredo M; Fernández-Novoa L; Corzo L; Zas R; Alcaraz M; Secades JJ; Lozano R; Cacabelos R
    Methods Find Exp Clin Pharmacol; 1999 Nov; 21(9):633-44. PubMed ID: 10669911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Agitated "unipolar" depression re-conceptualized as a depressive mixed state: implications for the antidepressant-suicide controversy.
    Akiskal HS; Benazzi F; Perugi G; Rihmer Z
    J Affect Disord; 2005 Apr; 85(3):245-58. PubMed ID: 15780694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of daily treatment with citicoline: a double-blind, placebo-controlled study in cocaine-dependent volunteers.
    Licata SC; Penetar DM; Ravichandran C; Rodolico J; Palmer C; Berko J; Geaghan T; Looby A; Peters E; Ryan E; Renshaw PF; Lukas SE
    J Addict Med; 2011 Mar; 5(1):57-64. PubMed ID: 21769048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lamotrigine compared to placebo and other agents with antidepressant activity in patients with unipolar and bipolar depression: a comprehensive meta-analysis of efficacy and safety outcomes in short-term trials.
    Solmi M; Veronese N; Zaninotto L; van der Loos ML; Gao K; Schaffer A; Reis C; Normann C; Anghelescu IG; Correll CU
    CNS Spectr; 2016 Oct; 21(5):403-418. PubMed ID: 27686028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of citicoline on functional and cognitive status among patients with traumatic brain injury: Citicoline Brain Injury Treatment Trial (COBRIT).
    Zafonte RD; Bagiella E; Ansel BM; Novack TA; Friedewald WT; Hesdorffer DC; Timmons SD; Jallo J; Eisenberg H; Hart T; Ricker JH; Diaz-Arrastia R; Merchant RE; Temkin NR; Melton S; Dikmen SS
    JAMA; 2012 Nov; 308(19):1993-2000. PubMed ID: 23168823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Citicoline in addictive disorders: a review of the literature.
    Wignall ND; Brown ES
    Am J Drug Alcohol Abuse; 2014 Jul; 40(4):262-8. PubMed ID: 24950234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Citicoline and Memory Function in Healthy Older Adults: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.
    Nakazaki E; Mah E; Sanoshy K; Citrolo D; Watanabe F
    J Nutr; 2021 Aug; 151(8):2153-2160. PubMed ID: 33978188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sustained-release methylphenidate in methamphetamine dependence treatment: a double-blind and placebo-controlled trial.
    Rezaei F; Emami M; Zahed S; Morabbi MJ; Farahzadi M; Akhondzadeh S
    Daru; 2015 Jan; 23(1):2. PubMed ID: 25588930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjunctive armodafinil for major depressive episodes associated with bipolar I disorder.
    Ketter TA; Yang R; Frye MA
    J Affect Disord; 2015 Aug; 181():87-91. PubMed ID: 25933099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Citicoline improves verbal memory in aging.
    Spiers PA; Myers D; Hochanadel GS; Lieberman HR; Wurtman RJ
    Arch Neurol; 1996 May; 53(5):441-8. PubMed ID: 8624220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preliminary randomized, double-blind, placebo-controlled trial of pramipexole added to mood stabilizers for treatment-resistant bipolar depression.
    Goldberg JF; Burdick KE; Endick CJ
    Am J Psychiatry; 2004 Mar; 161(3):564-6. PubMed ID: 14992985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized, double-blind, placebo-controlled, trial of lamotrigine therapy in bipolar disorder, depressed or mixed phase and cocaine dependence.
    Brown ES; Sunderajan P; Hu LT; Sowell SM; Carmody TJ
    Neuropsychopharmacology; 2012 Oct; 37(11):2347-54. PubMed ID: 22669171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.